StockData
Kymera Therapeutics, Inc. logo

Kymera Therapeutics, Inc. (KYMR) stock

KYMRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/30227% above fair value
$121.13−0.39 (-0.32%)

Close on Nov 18, 2026Market cap $10.34BP/E –Yield –

Kymera Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Kymera Therapeutics's market cap was $11.16B on Nov 11, 2026, against $4.87B a year earlier. Over the last 5 years it ranged from $646.40M to $11.16B, with a median of $2.18B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$11.16B+100.0%
2025Dec 31, 2025$5.58B+114.3%
2024Dec 31, 2024$2.60B+84.5%
2023Dec 29, 2023$1.41B+3.3%
2022Dec 30, 2022$1.37B-58.0%
2021Dec 31, 2021$3.25B+18.1%
2020Dec 31, 2020$2.76B–

More Kymera Therapeutics figures

See a number that looks wrong?